Maharashtra FDA suspends manufacturing at Sequent Scientific’s Mahad unit

17 Jun 2016 Evaluate

The Maharashtra Food and Drug Administration (FDA) has ordered suspension of the manufacturing at the Mahad unit of Sequent Scientific for a period of 15 days, starting July 1 to July 15, 2016. The company is hopeful of getting the process completed in the next couple of days. In the meantime, the unit continues to operate and the company expects no business interruptions.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals.

Viyash Scientific Share Price

201.30 7.20 (3.71%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×